Page 2 - Precision Medicine Program News Today

Six University of Michigan scientists and engineers have been named the 2022 winners of the MBioFAR Award, which recognizes exceptional mid-career faculty in the biosciences. MBioFAR, which stands for Mid-career Biosciences Faculty Achievement Recognition, is an annual award established last year

MOULTRIE, Ga. – CURE, an Atlanta-based non-profit organization, recently hosted an inaugural Catie’s Gathering event in Moultrie to raise funds for childhood cancer research.

/PRNewswire/ -- GO2 Foundation for Lung Cancer announced today that it will present Dr. Rafael Rosell with the 2022 Bonnie J. Addario Lectureship Award for his...

LARKSPUR, Calif.--(BUSINESS WIRE)--Jul 6, 2022--

Biohaven and Vigeo Now Enrolling in GBM AGILE, Registrational Phase 2-3 Adaptive Platform Trial to Evaluate Interventions for Patients With GlioblastomaLARKSPUR, Calif.--(BUSINESS WIRE)--#GBMAGILE--Global Coalition for Adaptive Research (LARKSPUR, CA), Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN), and V...

The ALS TDI scientists will be showcasing significant advancements in ALS research through multiple poster presentations. These posters will cover...

For the latest World of Genomics, we head over to Estonia – famous for its dense woodlands, charming historic sites and over 2,000 islands.

Tom Mikkelsen, M.D., leads Henry Ford’s Precision Medicine program and research efforts on glioblastoma.

In spite of decades of research, cancer remains an enigma. Conventional wisdom holds that cancer is driven by random mutations that create aberrant cells that run amok in the body. In a new paper published this week in the journal BioEssays, Arizona and Australian researchers challenge this model by proposing that cancer is a type of genetic throwback, that progresses via a series of reversions to ancestral forms of life.

 28 Apr 2021 - 13:45 The Peninsula Doha: Researchers at Sidra Medicine have identified spots within the novel coronavirus SARS‐CoV2 that do not mutate; paving the way for future vaccine design that can address variants of the virus. Mutations in the novel coronavirus SARS‐CoV2 are a major concern as they might lead to drug or vaccine resistance. Although most mutations may be detrimental to the viruss function, some will confer a significant advantage to the virus, helping it propagate an...